Lytham Partners, a leading investor relations firm, today announced the schedule for its Fall 2024 Investor Conference taking ...

MannKind (MNKD) reported top-level 30-week results from Phase 4 INHALE-3 study, in which additional patients living with type 1 ...

Check the time stamp on this data. Updated AI-Generated Signals for Mannkind Corporation (MNKD) available here: MNKD.

Discover MannKind Corp's innovative patent for synthesizing N-protected 3,6-aminoalkyl-2,5-diketopiperazines, enhancing organic chemistry and pharmaceutical advancements.

On Friday, MannKind Corp (MNKD) stock saw a decline, ending the day at $6.6 which represents a decrease of $-0.10 or -1.49% from the prior close of $6.7. The stock opened at $6.7 and touched a low of ...

We recently compiled a list of the 14 Worst 52-Week High Stocks to Buy According to Short Sellers. In this article, we are ...

MannKind Corp (MNKD) stock saw a modest uptick, ending the day at $6.66 which represents a slight increase of $0.10 or 1.52% from the prior close of $6.56. The stock opened at $6.61 and touched a low ...

MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of innovative inhaled therapeutic products and devices for patients with endocrine and orphan lung ...

The volatility ratio for the week is 4.32%, and the volatility levels for the last 30 days are 4.91% for Mannkind Corp . The simple moving average for the past 20 days is 13.00% for MNKD’s stock, with ...

DHAKA, Sept 15, 2024 (BSS) – Bangladesh Nationalist Party (BNP) Acting Chairman Tarique Rahman today said Prophet Hazrat Muhammad (PBUH) is a shining role model for world’s mankind. “The birth of ...

MannKind Corporation (NASDAQ:MNKD) is a U.S.-based biopharmaceutical company focused on developing and commercializing ...